Asymchem Laboratories Tianjin Co (SZSE:002821) 3-Year Revenue Growth Rate : 31.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co 3-Year Revenue Growth Rate?

Asymchem Laboratories Tianjin Co's Revenue per Share for the three months ended in Mar. 2024 was ¥3.77.

During the past 12 months, Asymchem Laboratories Tianjin Co's average Revenue per Share Growth Rate was -32.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 31.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 36.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Asymchem Laboratories Tianjin Co was 54.30% per year. The lowest was 16.00% per year. And the median was 25.60% per year.

Competitive Comparison of Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate falls into.

Asymchem Laboratories Tianjin Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Asymchem Laboratories Tianjin Co (SZSE:002821) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Asymchem Laboratories Tianjin Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

06821:Hong Kong 7K90:Germany

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.

Executives

Xiao Yi	Executives
Xu Xiang Ke	Directors, executives
Zhou Yan	Executives
Chen Chao Yong	Executives
Huang Xiao Lian	Executives
Yang Jing	Director
	Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines